NUCB2 and treatment resistant depression: Together with the results that no significant changes were observed in serum cortisol, nesfatin-1, and pro-inflammatory cytokine levels after MECT, which further suggests that MECT does not affect serum cortisol, nesfatin-1, and pro-inflammatory cytokine levels but reduces depressive symptoms in patients with TRD.